These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5696995)

  • 1. [Quantitative analysis and mechanisms of bradykinesia in patients with Parkinson's disease].
    Schneider P
    Dtsch Z Nervenheilkd; 1968; 194(2):89-102. PubMed ID: 5696995
    [No Abstract]   [Full Text] [Related]  

  • 2. Electromyographic analysis of a rapid volitional movement.
    Wiesendanger M; Schneider P; Villoz JP
    Am J Phys Med; 1969 Feb; 48(1):17-24. PubMed ID: 5764646
    [No Abstract]   [Full Text] [Related]  

  • 3. Visuomotor control of leg tracking in patients with Parkinson's disease or chorea.
    Yanagisawa N; Fujimoto S; Tanaka R
    Adv Neurol; 1983; 39():883-8. PubMed ID: 6660126
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinsonian bradykinesia is due to depression in the rate of rise of muscle activity.
    Godaux E; Koulischer D; Jacquy J
    Ann Neurol; 1992 Jan; 31(1):93-100. PubMed ID: 1543354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-latency myotatic reflexes in man: mechanisms, functional significance, and changes in patients with Parkinson's disease or hemiplegia.
    Lee RG; Murphy JT; Tatton WG
    Adv Neurol; 1983; 39():489-508. PubMed ID: 6419555
    [No Abstract]   [Full Text] [Related]  

  • 6. Reaction time in Parkinson's disease.
    Evarts EV; Teräväinen H; Calne DB
    Brain; 1981 Mar; 104(Pt 1):167-86. PubMed ID: 7470841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction times of movement preparation in patients with Parkinson's disease.
    Kaneoke Y; Koike Y; Sakurai N; Takahashi A; Watanabe S
    Neurology; 1989 Dec; 39(12):1615-8. PubMed ID: 2586778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiological mechanism of bradykinesia.
    Hallett M; Khoshbin S
    Brain; 1980 Jun; 103(2):301-14. PubMed ID: 7397480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slowness of movement in Parkinson's disease.
    Marsden CD
    Mov Disord; 1989; 4 Suppl 1():S26-37. PubMed ID: 2657408
    [No Abstract]   [Full Text] [Related]  

  • 10. Response slowing in Parkinson's disease: a psychophysiological analysis of premotor and motor processes.
    Low KA; Miller J; Vierck E
    Brain; 2002 Sep; 125(Pt 9):1980-94. PubMed ID: 12183344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous reflexes in Parkinson's disease.
    Fuhr P; Zeffiro T; Hallett M
    Muscle Nerve; 1992 Jun; 15(6):733-9. PubMed ID: 1508237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal inhibition between the forearm muscles in patients with Parkinson's disease.
    Nakashima K; Shimoyama R; Yokoyama Y; Takahashi K
    Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):67-72. PubMed ID: 8187680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premovement silence of EMG activity prior to movement in Parkinson patients.
    Palmer SS; Eisenberg P; Mortimer JA
    Electromyogr Clin Neurophysiol; 1991; 31(7):425-31. PubMed ID: 1748079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of function of the extraocular muscles in Parkinson's disease.
    Chaco J
    Ophthalmologica; 1971; 162(6):343-7. PubMed ID: 5131966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
    Kaufmann W; Butz P; Wiesendanger M
    Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
    [No Abstract]   [Full Text] [Related]  

  • 17. Premovement facilitation of corticospinal excitability in patients with Parkinson's disease.
    Hiraoka K; Notani M; Iwata A; Minamida F; Abe K
    Int J Neurosci; 2010 Feb; 120(2):104-9. PubMed ID: 20199201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociated changes of short- and long-latency myotatic responses prior to a brisk voluntary movement in normals, in karate experts, and in Parkinsonian patients.
    Mortimer JA; Webster DD
    Adv Neurol; 1983; 39():541-54. PubMed ID: 6660107
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscle relaxation in Parkinson's disease: a reaction time study.
    Grasso M; Mazzini L; Schieppati M
    Mov Disord; 1996 Jul; 11(4):411-20. PubMed ID: 8813221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic analysis of early Parkinson's disease.
    Watts RL; Mandir AS; Ahn KJ; Juncos JL; Zakers GO; Freeman A
    Geriatrics; 1991 Aug; 46 Suppl 1():31-6. PubMed ID: 1894142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.